Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Nicolas Peruzzo"'
Publikováno v:
The American Journal of Medicine. 136:e87-e89
Publikováno v:
The American Journal of Medicine.
Autor:
Nicolas Peruzzo, Jeziel Basso, Pedro Grachinski Buiar, Gustavo Gössling, Gilberto Schwartsmann
Publikováno v:
The American Journal of Medicine.
Autor:
Nicolas Peruzzo, Ricardo Siegle, Rafael Drevs Tesche, Gustavo Gössling, Luiza Ferreira Sperb, Pedro Grachinski Buiar, Jeziel Basso, Giovani Marino Favero, Iuri Martin Goemann
Publikováno v:
Journal of Travel Medicine. 30
Autor:
Fernando de Souza Pereira, Nicolas Peruzzo, Gustavo Gössling, Gilberto Schwartsmann, Rafaela Kathrine da Silva, Mauricio Guidi Saueressig, Leonardo de Brittes Andrade, Marcio F. Chedid, Aparna Raj Parikh
Publikováno v:
Journal of Clinical Oncology. 38:4034-4034
4034 Background: Indications for PM in pts with mCRC are often based on the presence of favorable prognostic factors. We aimed to analyze the prognostic factors and outcomes of pts treated with PM for mCRC. Methods: We retrospectively identified pts
Autor:
Rafaela Kathrine da Silva, Eduardo Ferreira Martins, Aparna Raj Parikh, Gustavo Gössling, Nicolas Peruzzo, Gilberto Schwartsmann, Bruno Siliprandi Pinto
Publikováno v:
Journal of Clinical Oncology. 38:e16535-e16535
e16535 Background: Despite low- and middle-income countries representing 80% of esophageal cancer global burden, TNM staging is based on data from the Worldwide Esophageal Cancer Collaboration (WECC) that is mainly composed of patients from developed
Publikováno v:
Journal of Clinical Oncology. 37:e16114-e16114
e16114 Background: Clear cell renal cell carcinoma (RCC) accounts for 3% of all cancers in Brazil, and the majority of these patients (pts) are treated in our public health system, SUS. Sunitinib and Pazopanib were incorporated into SUS in early 2019
Autor:
Nicolas Peruzzo, Débora Leite Rocha, Gustavo Gössling, Patricia Ashton-Prolla, Tiago Finger Andreis, Pedro Grachinski Buiar, Juliano Ce Coelho, Gabriel de Souza Macedo
Publikováno v:
Journal of Clinical Oncology. 37:e20668-e20668
e20668 Background: Lung cancer is the leading cause of cancer deaths globally. In stage IV non-small cell lung cancer (NSCLC), identification of a tumor driver mutation is critical, since it tailors treatment. We aimed to analyze clinical outcomes ac
Autor:
Panagiotis J. Vlachostergios, Scott T. Tagawa, Nicolas Peruzzo, Ana M. Molina, Clara Oromendia, David M. Nanus, Jyothi Manohar, Himisha Beltran, Jones T. Nauseef
Publikováno v:
Journal of Clinical Oncology. 37:278-278
278 Background: NEPC, de novo or treatment-related in late stage CRPC, is a distinct entity with poor prognosis. Developing non-invasive methods for detection of NEPC is important for clinical practice and trial enrollment. We previously reported on
Publikováno v:
Journal of Microbiology & Biology Education, Vol 20, Iss 1 (2019)
New educational resources are being implemented as an initiative to foster learning. In order to contribute to the toolkit of innovative educational resources, we developed a microbiology comic book. The aim of this comic is to provide educators with
Externí odkaz:
https://doaj.org/article/5e9162fe59494153ade998c0a29938ae